Form 8-K - Current report:
SEC Accession No. 0000950170-24-122291
Filing Date
2024-11-06
Accepted
2024-11-06 16:10:00
Documents
14
Period of Report
2024-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-20241106.htm   iXBRL 8-K 57267
2 EX-1.1 scyx-ex1_1.htm EX-1.1 370303
3 EX-5.1 scyx-ex5_1.htm EX-5.1 22791
4 GRAPHIC img192767529_0.jpg GRAPHIC 3378
  Complete submission text file 0000950170-24-122291.txt   635776

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20241106.xsd EX-101.SCH 24862
16 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20241106_htm.xml XML 4706
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 241430996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)